Kennedy Bond
Vice President, Clinical Development – Respiratory Diseases
Remote (US-based)
We are partnering with an innovative biopharmaceutical company at the forefront of respiratory disease research. Focused on developing transformative therapies for patients living with asthma, COPD, pulmonary fibrosis, and other respiratory conditions, the company leverages precision medicine, biomarkers, and patient-centric strategies to address significant unmet medical needs.
The Role We are seeking an accomplished
Vice President, Clinical Development (Respiratory Diseases)
to lead the strategic direction, design, and execution of the company’s respiratory portfolio. This senior leadership role will be instrumental in advancing programs from early clinical development through regulatory submission and commercialization, working cross-functionally to deliver meaningful impact for patients.
Key Responsibilities
Provide strategic and scientific leadership across all clinical development programs within the respiratory disease portfolio. Design, oversee, and execute Phase I–IV clinical trials, ensuring scientific rigor, operational excellence, and compliance with global regulatory standards. Partner with regulatory affairs, translational science, and medical affairs to implement integrated clinical strategies aligned with corporate objectives. Build, mentor, and lead a high-performing global clinical development team committed to innovation, collaboration, and scientific excellence. Cultivate strong relationships with pulmonologists, respiratory disease KOLs, academic institutions, and patient advocacy groups. Stay abreast of advances in respiratory science, biomarkers, digital health endpoints, and disease-modifying therapies to inform clinical strategy.
About You
MD or MD/PhD (or equivalent) with board certification in Pulmonology. 12+ years of progressive experience in clinical development, with deep expertise in respiratory disorders. Proven track record of advancing respiratory programs through key regulatory milestones (IND, NDA/BLA) and global submissions. Strong understanding of respiratory trial design, clinical endpoints (lung function, symptom scores, biomarkers), and biomarker strategies. Demonstrated leadership, strategic thinking, and ability to collaborate across functions and geographies. Passion for transforming the lives of patients affected by respiratory diseases through innovation and clinical excellence.
Please contact: Melissa Mallison | m.mallison@kennedybond.com
We are partnering with an innovative biopharmaceutical company at the forefront of respiratory disease research. Focused on developing transformative therapies for patients living with asthma, COPD, pulmonary fibrosis, and other respiratory conditions, the company leverages precision medicine, biomarkers, and patient-centric strategies to address significant unmet medical needs.
The Role We are seeking an accomplished
Vice President, Clinical Development (Respiratory Diseases)
to lead the strategic direction, design, and execution of the company’s respiratory portfolio. This senior leadership role will be instrumental in advancing programs from early clinical development through regulatory submission and commercialization, working cross-functionally to deliver meaningful impact for patients.
Key Responsibilities
Provide strategic and scientific leadership across all clinical development programs within the respiratory disease portfolio. Design, oversee, and execute Phase I–IV clinical trials, ensuring scientific rigor, operational excellence, and compliance with global regulatory standards. Partner with regulatory affairs, translational science, and medical affairs to implement integrated clinical strategies aligned with corporate objectives. Build, mentor, and lead a high-performing global clinical development team committed to innovation, collaboration, and scientific excellence. Cultivate strong relationships with pulmonologists, respiratory disease KOLs, academic institutions, and patient advocacy groups. Stay abreast of advances in respiratory science, biomarkers, digital health endpoints, and disease-modifying therapies to inform clinical strategy.
About You
MD or MD/PhD (or equivalent) with board certification in Pulmonology. 12+ years of progressive experience in clinical development, with deep expertise in respiratory disorders. Proven track record of advancing respiratory programs through key regulatory milestones (IND, NDA/BLA) and global submissions. Strong understanding of respiratory trial design, clinical endpoints (lung function, symptom scores, biomarkers), and biomarker strategies. Demonstrated leadership, strategic thinking, and ability to collaborate across functions and geographies. Passion for transforming the lives of patients affected by respiratory diseases through innovation and clinical excellence.
Please contact: Melissa Mallison | m.mallison@kennedybond.com